Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver
- 24 September 1985
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 80 (2), 185-192
- https://doi.org/10.1016/0041-008x(85)90074-2
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Cholestasis Induced by Estradiol-17β-D-Glucuronide: Mechanisms and Prevention by Sodium Taurocholate†Hepatology, 1984
- Erythromycin Estolate vs. Erythromycin Base, Surface Excess Properties and Surface Scanning Changes in Isolated Liver Cell SystemsPharmacology, 1980
- Cytotoxic effects of erythromycin estolate and chlorpromazine on hepatocytes isolated from rats of varying ages: A brief noteMechanisms of Ageing and Development, 1980
- Biliary excretion of erythromycin after parenteral administration.British Journal of Clinical Pharmacology, 1979
- Cholestatic and hepatocellular injury associated with erythromycin estersDigestive Diseases and Sciences, 1979
- Hepatotoxic and cellular uptake interactions among surface active components of erythromycin preparationsBiochemical Pharmacology, 1978
- Inhibition of Na+, K+-Adenosinetriphosphatase by Endotoxin: A Possible Mechanism for Endotoxin-Induced CholestasisThe Journal of Infectious Diseases, 1977
- Properties of (Na+ + K+)-activated ATPase in rat liver plasma membranes enriched with bile canaliculiBiochimica et Biophysica Acta (BBA) - Biomembranes, 1975
- Determination of the biliary dead space usign14C-taurocholate as a markerCellular and Molecular Life Sciences, 1973
- Hepatotoxicity of ErythromycinThe Journal of Infectious Diseases, 1969